Equities

Hikal Ltd

Hikal Ltd

Actions
Health CarePharmaceuticals and Biotechnology
  • Price (INR)386.50
  • Today's Change8.00 / 2.11%
  • Shares traded462.24k
  • 1 Year change+26.31%
  • Beta1.6498
Data delayed at least 15 minutes, as of Sep 20 2024 11:25 BST.
More ▼
Find More Stocks
Find More Stocks
Use our equities screener to discover other potential opportunities.
 
Equities ScreenerGo to the Equities Screener

Financials data is unavailable for this security.

Balance sheet Back to Overview

In millions of INR
(except for per share items)
Fiscal data as of Mar 31 2024202420232022
ASSETS
Cash And Short Term Investments207593591
Total Receivables, Net6,0665,2965,406
Total Inventory3,2003,3403,491
Prepaid expenses136159152
Other current assets, total572.442.48
Total current assets9,6669,3909,643
Property, plant & equipment, net14,74813,50311,640
Goodwill, net------
Intangibles, net101102103
Long term investments59240153
Note receivable - long term115305239
Other long term assets177306348
Total assets24,87123,85522,131
LIABILITIES
Accounts payable2,7883,1332,491
Accrued expenses1507972
Notes payable/short-term debt2,8861,7332,726
Current portion long-term debt/capital leases1,0358501,155
Other current liabilities, total7078211,248
Total current liabilities7,5666,6167,692
Total long term debt4,2554,8992,869
Total debt8,1767,4826,750
Deferred income tax300327364
Minority interest------
Other liabilities, total873679526
Total liabilities12,99512,52011,451
SHAREHOLDERS EQUITY
Common stock247247247
Additional paid-in capital381381381
Retained earnings (accumulated deficit)11,25110,70910,055
Treasury stock - common------
Unrealized gain (loss)------
Other equity, total(1.89)(2.24)(2.56)
Total equity11,87711,33510,680
Total liabilities & shareholders' equity24,87123,85522,131
Total common shares outstanding123123123
Treasury shares - common primary issue000
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.